FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Care and Connection That Matter

Access to care, trusted guidance, and meaningful programs that support individuals and families—every step of the way.

MDA Engage Community Education Seminar: Tennessee

Saturday, October 5, 2019
Registration 8:30am – 9:00am
Event: 9:00am-3:00pm (lunch included)
Social Hour: 3:00pm - 4:00pm

Event Chairs: Dr. Peter Donofrio, Neurologist, Director of MDA Care Center, Vanderbilt Hospital

Event Location:
Nashville Marriott at Vanderbilt University
2555 West End Ave.
Nashville, TN 37203

There is no cost to attend the event, however, registration is required.

Registration has closed

 

  • Keynote Presentation- Overview of Muscular Dystrophy
    • Dr. Peter Donofrio, Vanderbilt University Medical Center
  • Genetics
    • Dr. Bryan Burnette, Vanderbilt University Medical Center
  • Therapies for NMD Panel Discussion
    • Penny Powers, PT, - Vanderbilt University Medical Center
    • Valery Hanks, OT, - Vanderbilt University Medical Center
    • Sarah Sawyers, Nutritionist - Vanderbilt University Medical Center
  • Financial Planning
    • Matt Moser -Capital Wealth Advisors
  • Clinical Trials and Update on Research in NMD
    • Dr. Michael Lopez- University of Alabama, Birmingham

 

Thank you to our supporters:

  • Sanofi Genzyme
  • Genentech

For questions reach out to: mdaengage@mdausa.org | 1-833-ASK-MDA1 (1-833-275-6321)